TrialBMC musculoskeletal disorders2016

Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.

Kara Bickham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.